Receiver operating characteristic ROC curve analysis revealed that urinary TIMP-1 and serum NGAL may be useful non-invasive biomarkers to provide clinical information for bladder cancer disease [51]. This evidence concerns the gene TIMP1 and urinary bladder carcinoma.